Literature DB >> 17910120

Stereoselective glucuronidation of carvedilol by Chinese liver microsomes.

Lin-ya You1, Chun-na Yu, Sheng-gu Xie, Shu-qing Chen, Su Zeng.   

Abstract

OBJECTIVE: To study the stereoselective glucuronidation of carvedilol (CARV) by three Chinese liver microsomes.
METHODS: The metabolites of CARV were identified by a hydrolysis reaction with beta-glucuronidase and HPLC-MS/MS. The enzyme kinetics for CARV enantiomers glucuronidation was determined by a reversed phase-high pressure liquid chromatography (RP-HPLC) assay using (S)-propafenone as internal standard after precolumn derivatization with 2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosylisothiocyanate.
RESULTS: Two CARV glucuronides were found in three Chinese liver microsomes incubated with CARV. The non-linear regression analysis showed that the values of K(m) and V(max) for (S)-CARV and (R)-CARV enantiomers were (118+/-44) micromol/L, (2 500+/-833) pmol/(min.mg protein) and (24+/-7) micromol/L, (953+/-399) pmol/(min.mg protein), respectively.
CONCLUSION: These results suggested that there was a significant (P<0.05) stereoselective glucuronidation of CARV enantiomers in three Chinese liver microsomes, which might partly explain the enantioselective pharmacokinetics of CARV.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17910120      PMCID: PMC1997231          DOI: 10.1631/jzus.2007.B0756

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  29 in total

Review 1.  Structural and functional studies of UDP-glucuronosyltransferases.

Authors:  A Radominska-Pandya; P J Czernik; J M Little; E Battaglia; P I Mackenzie
Journal:  Drug Metab Rev       Date:  1999-11       Impact factor: 4.518

2.  The importance of local chemical structure for chemical metabolism by human uridine 5'-diphosphate-glucuronosyltransferase.

Authors:  Michael J Sorich; Ross A McKinnon; John O Miners; Paul A Smith
Journal:  J Chem Inf Model       Date:  2006 Nov-Dec       Impact factor: 4.956

3.  Evaluation of effects of polymorphism for metabolic enzymes on pharmacokinetics of carvedilol by population pharmacokinetic analysis.

Authors:  Yoh Takekuma; Toru Takenaka; Masami Kiyokawa; Koujiro Yamazaki; Hiroshi Okamoto; Akira Kitabatake; Hiroyuki Tsutsui; Mitsuru Sugawara
Journal:  Biol Pharm Bull       Date:  2007-03       Impact factor: 2.233

4.  Combination therapy with carvedilol and amiodarone in patients with severe heart failure.

Authors:  H Nägele; M Bohlmann; U Eck; B Petersen; W Rödiger
Journal:  Eur J Heart Fail       Date:  2000-03       Impact factor: 15.534

5.  Stereoselective determination of p-hydroxyphenyl-phenylhydantoin enantiomers in rat liver microsomal incubates by reversed-phase high-performance liquid chromatography using beta-cyclodextrin as chiral mobile phase additives.

Authors:  T W Yao; S Zeng
Journal:  Biomed Chromatogr       Date:  2001-04       Impact factor: 1.902

6.  Stereoselective determination of propafenone enantiomers in transgenic Chinese hamster CHL cells expressing human cytochrome P450.

Authors:  T W Yao; Q Zhou; S Zeng
Journal:  Biomed Chromatogr       Date:  2000-11       Impact factor: 1.902

7.  Contribution of polymorphisms in UDP-glucuronosyltransferase and CYP2D6 to the individual variation in disposition of carvedilol.

Authors:  Yoh Takekuma; Toru Takenaka; Masami Kiyokawa; Koujiro Yamazaki; Hiroshi Okamoto; Akira Kitabatake; Hiroyuki Tsutsui; Mitsuru Sugawara
Journal:  J Pharm Pharm Sci       Date:  2006       Impact factor: 2.327

8.  Effect of CYP2D6*10 on the pharmacokinetics of R- and S-carvedilol in healthy Japanese volunteers.

Authors:  Mutsuko Honda; Takashi Nozawa; Norio Igarashi; Hiroshi Inoue; Rie Arakawa; Yumi Ogura; Hiromi Okabe; Masato Taguchi; Yukiya Hashimoto
Journal:  Biol Pharm Bull       Date:  2005-08       Impact factor: 2.233

9.  Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein.

Authors:  M D Green; T R Tephly
Journal:  Drug Metab Dispos       Date:  1996-03       Impact factor: 3.922

10.  Involvement of human hepatic UGT1A1, UGT2B4, and UGT2B7 in the glucuronidation of carvedilol.

Authors:  Akiko Ohno; Yoshiro Saito; Nobumitsu Hanioka; Hideto Jinno; Mayumi Saeki; Masanori Ando; Shogo Ozawa; Jun-ichi Sawada
Journal:  Drug Metab Dispos       Date:  2004-02       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.